Literature DB >> 9294121

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

J Zabner1, S H Cheng, D Meeker, J Launspach, R Balfour, M A Perricone, J E Morris, J Marshall, A Fasbender, A E Smith, M J Welsh.   

Abstract

Cationic lipids show promise as vectors for transfer of CFTR cDNA to airway epithelia of patients with cystic fibrosis (CF). However, previous studies have not compared the effect of DNA-lipid to DNA alone. Recently, we developed a formulation of plasmid encoding CFTR (pCF1-CFTR) and cationic lipid (GL-67:DOPE) that generated greater gene transfer in mouse lung than previously described DNA-lipid vectors. Therefore, we tested the hypothesis that DNA-lipid complexes were more effective than DNA alone at transferring CFTR cDNA to airway epithelia in vivo. We administered complexes of DNA-lipid to one nostril and DNA alone to the other nostril in a randomized, double-blind study. Electrophysiologic measurements showed that DNA-lipid complexes partially corrected the Cl- transport defect. Importantly, the pCF1-CFTR plasmid alone was at least as effective as complexes of DNA with lipid. Measurements of vector-specific CFTR transcripts also showed gene transfer with both DNA-lipid and DNA alone. These results indicate that nonviral vectors can transfer CFTR cDNA to airway epithelia and at least partially restore the Cl- transport defect characteristic of CF. However, improvements in the overall efficacy of gene transfer are required to develop a treatment for CF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294121      PMCID: PMC508334          DOI: 10.1172/JCI119676

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Asymmetry in the nasal mucociliary transport rate.

Authors:  J Nuutinen
Journal:  Laryngoscope       Date:  1996-11       Impact factor: 3.325

2.  Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells.

Authors:  H Matsui; L G Johnson; S H Randell; R C Boucher
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

3.  Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.

Authors:  E R Lee; J Marshall; C S Siegel; C Jiang; N S Yew; M R Nichols; J B Nietupski; R J Ziegler; M B Lane; K X Wang; N C Wan; R K Scheule; D J Harris; A E Smith; S H Cheng
Journal:  Hum Gene Ther       Date:  1996-09-10       Impact factor: 5.695

4.  Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.

Authors:  J G Hay; N G McElvaney; J Herena; R G Crystal
Journal:  Hum Gene Ther       Date:  1995-11       Impact factor: 5.695

5.  Direct gene transfer to mouse melanoma by intratumor injection of free DNA.

Authors:  J P Yang; L Huang
Journal:  Gene Ther       Date:  1996-06       Impact factor: 5.250

6.  Naked DNA delivered intraportally expresses efficiently in hepatocytes.

Authors:  V Budker; G Zhang; S Knechtle; J A Wolff
Journal:  Gene Ther       Date:  1996-07       Impact factor: 5.250

7.  Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood.

Authors:  M Y Levy; L G Barron; K B Meyer; F C Szoka
Journal:  Gene Ther       Date:  1996-03       Impact factor: 5.250

8.  Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.

Authors:  S K Tripathy; E C Svensson; H B Black; E Goldwasser; M Margalith; P M Hobart; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

Authors:  N J Caplen; E W Alton; P G Middleton; J R Dorin; B J Stevenson; X Gao; S R Durham; P K Jeffery; M E Hodson; C Coutelle
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo.

Authors:  I Nita; S C Ghivizzani; J Galea-Lauri; G Bandara; H I Georgescu; P D Robbins; C H Evans
Journal:  Arthritis Rheum       Date:  1996-05
View more
  22 in total

Review 1.  The role of CpG in DNA vaccines.

Authors:  M J McCluskie; R D Weeratna; H L Davis
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 3.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

4.  Rapid identification of novel functional promoters for gene therapy.

Authors:  Ian A Pringle; Deborah R Gill; Mary M Connolly; Anna E Lawton; Anne-Marie Hewitt; Graciela Nunez-Alonso; Seng H Cheng; Ronald K Scheule; Lee A Davies; Stephen C Hyde
Journal:  J Mol Med (Berl)       Date:  2012-07-06       Impact factor: 4.599

5.  Electrohydrodynamic comminution: a novel technique for the aerosolisation of plasmid DNA.

Authors:  Lee A Davies; Kevin Hannavy; Neville Davies; Alistair Pirrie; Ronald A Coffee; Stephen C Hyde; Deborah R Gill
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

6.  Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Authors:  A M Krieg; T Wu; R Weeratna; S M Efler; L Love-Homan; L Yang; A K Yi; D Short; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 7.  Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Authors:  Mayumi Oakland; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

Review 8.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 9.  Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Authors:  Steven M Rowe; Frank Accurso; John P Clancy
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 10.  Nanodelivery in airway diseases: challenges and therapeutic applications.

Authors:  Indrajit Roy; Neeraj Vij
Journal:  Nanomedicine       Date:  2009-07-16       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.